Achieve Complete Compliance and Protect Your Workforce with Expert Validation Services
At Indivirtus Healthcare Services, our specialized Containment Performance Testing services provide comprehensive validation of containment systems for high-potency APIs, cytotoxic medications, and hazardous pharmaceutical compounds. Through proven SMEPAC methodologies, we guarantee operator safety, maintain product integrity, and ensure full compliance with international regulatory standards using data-driven validation solutions.
Our comprehensive Containment Performance Testing service evaluates containment system effectiveness using industry-standard SMEPAC methodologies. Through precise airborne monitoring, detailed surface mapping, and personal exposure sampling, we verify full compliance with occupational exposure limits (OELs) to safeguard both personnel and pharmaceutical products.
Working with potent pharmaceutical compounds presents serious risks to both operators and product quality. Our expert testing ensures your containment systems perform consistently and reliably, protecting workforce safety, preventing cross-contamination, and meeting strict regulatory requirements to keep your facility audit-ready at all times.
Indivirtus Healthcare Services combines cutting-edge analytical techniques with extensive regulatory expertise to deliver customized containment validation solutions. We provide actionable insights and practical recommendations to optimize your containment systems, ensuring complete operator safety and seamless compliance with global pharmaceutical standards.
At Indivirtus Healthcare Services, we employ industry-leading SMEPAC (Standardized Measurement of Equipment Particulate Airborne Concentration) methodologies to thoroughly validate containment systems in high-potency API facilities. Our systematic approach includes continuous real-time airborne particulate monitoring to accurately assess exposure risks, comprehensive surface contamination mapping to identify critical operational zones, and precise personal breathing zone sampling to measure operator exposure across 8-hour TWA periods and peak exposure events.
We utilize state-of-the-art gravimetric and chemical analysis techniques, including advanced HPLC and LC-MS/MS technologies, to precisely quantify pharmaceutical residues and confirm compliance with established OELs. Our validated protocols fully align with ISPE Good Practice Guides and international GMP standards, incorporating challenging worst-case scenarios to thoroughly stress-test your containment strategies. The outcome is a comprehensive dataset with customized recommendations to address any containment breaches, ensuring complete operator safety and regulatory compliance readiness.
Comprehensive SMEPAC-Compliant Qualification Report: Complete documentation with detailed risk assessments and compliance findings.
Detailed Operator Exposure Profiles: Precise data on 8-hour TWA and peak exposure levels for enhanced personnel safety.
Advanced 3D Contamination Mapping: Professional visual representations of critical zones identifying potential contamination risks.
Professional Gravimetric & Chemical Analysis Reports: Accurate quantification of residues using advanced analytical methodologies.
Comparative Performance Analysis: Thorough evaluation of containment system performance against established OEL thresholds.
Targeted Corrective Action Recommendations: Customized strategies to address containment breaches and enhance overall safety.
Our Containment Performance Testing services strictly adhere to the most stringent international regulatory standards, ensuring your containment systems remain audit-ready and fully compliant. By aligning with industry-leading guidelines and best practices, we provide scientifically defensible documentation and proven processes that withstand regulatory scrutiny, giving you complete confidence in your safety protocols and compliance strategies.
Our Containment Performance Testing services are essential for pharmaceutical and biotechnology facilities handling high-potency APIs, cytotoxic medications, or hazardous pharmaceutical compounds. Whether you're validating new containment systems, conducting routine performance evaluations, or preparing for critical regulatory audits, our services ensure complete compliance and safety. Primary applications include verifying isolator performance for cytotoxic drug manufacturing, optimizing containment strategies in multi-product facilities, and ensuring operator safety during high-risk pharmaceutical operations. We support facilities at every stage of development, from innovative startups to established pharmaceutical manufacturers, helping achieve regulatory success and operational excellence.
Indivirtus Healthcare Services brings together certified toxicologists and regulatory specialists with advanced analytical capabilities to deliver unmatched Containment Performance Testing services. Our scientifically rigorous approach guarantees defensible results, rapid project turnaround times, and strict confidentiality to protect your proprietary pharmaceutical data. With customized testing protocols and practical recommendations, we help you safeguard your workforce, maintain regulatory compliance, and achieve operational excellence in high-potency pharmaceutical environments.
SMEPAC provides standardized, quantitative metrics for comparing containment performance across different equipment types using controlled test materials and validated protocols, while traditional testing methods often rely on product-specific testing without standardized benchmarking capabilities.
We employ engineered challenge tests using validated surrogate materials under exaggerated operating conditions including higher processing speeds, extended durations, and maximum payload capacities to identify potential failure modes and establish proper safety margins.
Yes, our comprehensive data-driven containment performance reports provide scientific justification for PPE optimization while maintaining complete worker safety, often helping facilities achieve ALARP (As Low As Reasonably Practicable) compliance standards.
We utilize a comprehensive combination of real-time particle counters, filter-based gravimetric sampling systems, and chemical-specific analysis including LC-MS/MS when required to capture both particulate mass concentrations and compound-specific exposure data.
We recommend annual revalidation schedules, with additional testing performed after equipment modifications, significant process changes, or when introducing new compounds with lower OELs than previously handled pharmaceutical materials.
Our complete service includes real-time airborne particulate monitoring, detailed surface contamination mapping, personal breathing zone sampling, advanced gravimetric/chemical analysis, and targeted corrective action recommendations, all performed using validated SMEPAC methodologies.
We strictly follow SMEPAC Guidelines (2021), ISPE Good Practice Guide standards, OSHA 29 CFR 1910.1000, ACGIH TLVs, EU GMP Annex 1 (2022), EMA HBEL guidelines, and NIOSH Hazardous Drug Handling standards.
You will receive a comprehensive SMEPAC-compliant qualification report, detailed operator exposure profiles, interactive 3D contamination mapping, complete residue analysis reports, thorough OEL performance analysis, and customized corrective action recommendations.
Professional testing is ideal for validating new containment systems, conducting routine performance evaluations, ensuring operator safety in cytotoxic drug manufacturing, or preparing for critical regulatory audits and compliance assessments.
We maintain strict confidentiality protocols and follow industry best practices to protect your proprietary pharmaceutical data throughout the entire testing process and reporting phase, ensuring complete data security.
Our SMEPAC-based approach combines advanced analytics, comprehensive worst-case testing scenarios, and customized recommendations to deliver precise, actionable data for optimizing containment systems and ensuring regulatory compliance.